|Articles|December 7, 2019

Recalls That Should Be on Your Radar—Week of December 1, 2019

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Fuji Food Products Issues Recall of Ready-to-Eat Sushi, Spring Rolls, and Salads Due to Possible Listeria monocytogenes Contamination

Fuji Food Products, Inc. has issued a voluntary recall of ready-to-eat sushi, salads, and spring rolls sold to retailers and distributors on the East Coast and in the upper-Midwest. The recall is based on a notification by the FDA of the potential for product contamination with Listeria monocytogenes.

The problem was discovered during routine inspection by the FDA, in the company’s Brockton Massachusetts facility. The company ceased production and distribution of products in the facility in response.

Read the recall statement.

UNFI Issues Recall of Wild Harvest Organic All Purpose Flour Due to Possible Escherichia coli Contamination

UNFI has issued a voluntary recall of 5-pound bags of Wild Harvest Organic All Purpose Flour, Unbleached, with a Code of AA BEST IF USED BY 010820 CC 15:58 and UPC Code 711535509158.

During routine FDA sampling of the 5-pound bag product, results were positive for E coli contamination. To date, UNFI has not received direct consumer reports of adverse events related to the recall.

Read the recall statement.

Hodgson Mill Issues Recall of Unbleached All Purpose White Wheat Flour Due to Possible E coli Contamination

Hodgson Mill has issued a voluntary national recall of Unbleached All Purpose White Wheat Flour, 5 pound bags.

Hodgson Mill discovered the problem because of the potential presence of E coli found during sampling of raw uncooked flour. The company has not received any confirmed adverse health reports related to the product.

Read the recall statement.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.